KALA BIO, Inc. Material Event - What Happened

Hey everyone, let's break down what's going on with KALA BIO, Inc. in a way that makes sense, without all the fancy finance talk. Think of this as me explaining the news to you over a cup of coffee.

---

1. What happened? (The Big News, Plain and Simple)

Basically, KALA BIO issued a total of 4.6 million new shares of its common stock to settle various debts and obligations, including payments to advisors, a marketing firm, and to resolve claims from a major investor, as well as to employees.

2. When did it happen?

This news just came out on December 30, 2025, with the official report filed on January 6, 2026.

3. Why did it happen? (The Story Behind the Story)

So, why did KALA BIO do this? Well, instead of paying cash, KALA BIO decided to use its own stock to settle several financial obligations. This included:

• Paying off a major investor (Baker Bros. Advisors LP): They issued 900,000 shares to resolve some past claims related to earlier funding arrangements. As part of this, Baker Bros. also agreed to let KALA BIO's board decide how to vote these new shares (and some others they already own) for the next six months.
• Paying for financial advice (LifeSci Capital LLC): They issued 2,200,000 shares to cover what they owed for financial advisory services.
• Paying for marketing and advertising (Delaware IR LLC): They issued 1,100,000 shares to settle a $600,000 payment for marketing services. Interestingly, there's a "make-whole" clause, meaning if the shares don't sell for at least $600,000, KALA BIO might have to make up the difference.
• Compensating employees: An additional 400,000 shares were given to employees.

This move suggests KALA BIO is conserving its cash by using its stock as currency to manage its finances and operations.

4. Why does this matter? (The "So What?" for Everyone)

This is a pretty big deal because issuing 4.6 million new shares significantly increases the total number of KALA BIO shares out there. When a company issues more shares, it generally "dilutes" the value of existing shares. Think of it like this: if you own a slice of a pizza, and then the pizza gets cut into more slices, your original slice now represents a smaller portion of the whole pizza. This means each existing share now represents a smaller piece of the company's ownership and future earnings. It also shows the company is actively using its stock to manage its financial obligations and operations.

5. Who is affected? (Who Feels the Impact?)

• Investors (that's you, if you own KALA BIO stock!): Your shares might experience dilution, meaning each share you own now represents a slightly smaller percentage of the company. This can sometimes put downward pressure on the stock price.
• Employees: Some employees received shares as compensation, which ties their personal financial interest more closely to the company's performance.
• Creditors/Advisors (Baker Bros., LifeSci, Delaware IR): These entities received shares instead of cash, making them new or larger shareholders. They now have a direct stake in KALA BIO's future stock performance. Baker Bros. also has a temporary agreement to vote their shares as the company's board recommends.
• KALA BIO as a Company: This event directly impacts their financial stability by allowing them to settle debts and secure services without spending cash. However, it comes at the cost of diluting existing shareholder ownership.

6. What happens next? (The Road Ahead)

Immediately, the newly issued shares are now part of the market. We'll need to watch for how these new shareholders (especially Baker Bros., LifeSci, and Delaware IR) manage their shares. If they decide to sell them, it could add more shares to the market, potentially affecting the stock price. The "make-whole mechanic" for Delaware IR means KALA BIO might have further obligations if the share price drops significantly below a certain point. The voting agreement with Baker Bros. will be in effect for six months, giving KALA BIO some control over a significant block of shares during that period.

7. What should investors/traders know? (Your Practical Takeaways)

If you're thinking about KALA BIO stock, here's what to keep in mind:

• Watch the Price: Expect some potential volatility or downward pressure on the stock price due to the increased number of shares (dilution) and the possibility of these new shares being sold on the open market.
• Look at the Big Picture: This is a financial management move, where KALA BIO used its equity (stock) to settle obligations and conserve cash. While it causes dilution, it also helps the company manage its immediate financial needs.
• Do Your Homework: Keep an eye out for any follow-up announcements from KALA BIO, especially regarding the "make-whole" clause with Delaware IR or any significant sales of these newly issued shares by the recipients.
• Consider Your Strategy: If you own the stock, think about how this dilution impacts your long-term view of the company. If you don't own it, does this create a potential buying opportunity if the price dips, or a reason to stay away for now given the increased share count?

---

Hope this helps you understand what's going on! We'll keep an eye on KALA BIO and let you know if anything major changes.